Back to discover
Drug

Racemethionine

Research stage
Emerging research
Also known as (+-)-Methionine, Cotameth, DL-Methionine, DL-Methioninum+3 more

(+-)-Methionine, Cotameth, DL-Methionine, DL-Methioninum, Methionine, Pedameth, metionina.

1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Racemethionine
Aliases & brands
(+-)-MethionineCotamethDL-MethionineDL-MethioninumMethioninePedamethmetionina
RxNorm CUI
9100
ChEMBL ID
CHEMBL274119
UNII
73JWT2K6T3

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Major research themes3
Gastrointestinal Microbiome1Hydrogen Sulfide1Neoplasms1
Journals, researchers & institutions
Top journals
  • Nature metabolism1
Leading researchers
  • Anantharaman K1
  • Andrea Azcarate-Peril M1
  • Arbeev KG1
  • Garcia-Peterson LM1
  • Hsiao YC1
  • Ji M1
  • Li JL1
  • Li X1
Leading institutions
free-text, unnormalised
  • Department of Microbiology and Immunology and Lineberger Comprehensive Cancer Center1
  • Duke University School of Medicine1
  • Epigenetics and Stem Cell Biology Laboratory1
  • Gillings School of Global Public Health1
  • National Institute of Environmental Health Sciences1
  • Signal Transduction Laboratory1

Related drugs

1 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across the same disease area as Racemethionine in the shared literature.

1 shared disease1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature